Understanding filler complications.
Recognize. Classify. Act.
Complications after hyaluronic acid filler treatments are overall rare — but when they occur, the right response is decisive. This educational page helps you understand which symptoms are relevant, which two clinical scenarios are to be distinguished, and how you should act in a specific case.
Rare — but no area is risk-free
Hyaluronic acid fillers are among the best-studied injectable treatments in aesthetic medicine. Over 40 million documented applications worldwide show a very low real-world complication rate.
Nevertheless, the following holds: even with the most careful anatomical preparation and ultrasound-guided injection technique, there exists no area of the face that is completely risk-free (DeLorenzi, Aesthet Surg J 2017). A vascular event can occur with any injection and in any practice — even with experienced practitioners. What determines the course is not experience alone, but the preparedness for the emergency and the speed of response.
"Complications are rare. Poorly managed complications are dramatic. Early action is the most important intervention of all."
Two clinical scenarios — two responsibilities
Filler complications occur in two different constellations that require completely different responses. This distinction is medically and practically decisive.
Acute vascular occlusion at the treatment table
An intravascular injection or vascular compression by filler material can occur seconds to minutes after the puncture. Recognizable through sudden, unusually severe pain and immediate skin pallor (blanching) in the perfusion area.
In this situation, the patient cannot act actively — the response is entirely in medical hands. What is decisive is that the practice is prepared for it: Hyaluronidase must be in stock, the staff must know the emergency protocol.
Delayed or late-recognized complication
A complication can also develop hours, days or weeks after the treatment — for example as increasing swelling, delayed-onset circulatory disturbance, signs of infection or nodule formation. Here the patient's self-observation is decisive.
Here it depends on you knowing which symptoms are harmless accompanying phenomena — and which require medical clarification. The next sections help you with this classification.
What is normal — what is not?
Most reactions after a filler treatment are harmless consequences of the small procedure. However, a few symptoms require prompt medical clarification. Here is the important distinction.
Mild swelling at the injection sites
Local swelling in the first 24-48 hours is normal and a consequence of the mechanical injection. It usually subsides on its own.
Small bruises (hematomas)
Small bruises at the injection sites are common — especially on the lips or under the eyes. They disappear over 5-10 days.
Pressure sensation, tension
A mild sensation of tension or pressure in the first week is a normal part of tissue adaptation to the introduced volume.
Asymmetry in the first days
Mild asymmetry in the first 1-2 days can arise from unequal swelling. An assessment of the final result occurs at the earliest after 14 days.
Sudden severe, burning pain
Pain that immediately during or shortly after the injection becomes significantly more severe than the usual prick — and does not subside within a few minutes. Particularly if it spreads from the injection site.
White, pale or mottled skin color
Sudden pallor (blanching) of the skin in the treatment area or a net-like, bluish-marbled pattern (livedo reticularis) are early signs of a circulatory disturbance.
Visual disturbances of any kind
Blurred vision, double vision, eye pain or sudden vision loss after a filler treatment — even if they only occur briefly. This requires immediate medical clarification.
Persistent, increasing swelling
Swelling that still increases significantly after 48 hours, becomes painful or reddens can indicate an infection or late reaction — both must be medically assessed.
Five stages — and the time factor
The international classification of a filler-induced vascular obstruction describes five stages. The earlier treatment begins, the better the prognosis. Within the first hours, complete resolution is achievable in most cases.
Blanching — immediate pallor
During or immediately after the injection, a sudden white or mottled discoloration of the skin develops, often accompanied by unusually severe pain. This is the earliest and most important warning sign — recognizable exclusively at the treatment table.
Livedo reticularis — net-like discoloration
The skin shows a bluish-marbled, net-like pattern in the affected perfusion area. Capillary refill (visible upon pressure with the finger) is delayed.
Blister formation and dark discoloration
Small blisters (pustules) form on the surface, the skin becomes darker to dark blue-reddish. The tissue no longer hurts severely — which, paradoxically, is a bad sign.
Necrosis signs — dead tissue
If not treated in time: formation of black crusts (eschar) as a sign of dead skin areas. Subsequent scar formation is difficult to avoid at this stage.
Healing or scarring phase
Depending on the course of treatment: complete healing possible (with early hyaluronidase administration), or formation of permanent scars with delayed therapy. This becomes apparent only after weeks.
"Hyaluronidase, administered as quickly as possible, is the only evidence-based therapy that can fully save the tissue. Ideally within the first hour."
DeLorenzi 2017 · Aesthet Surg J 37(7):814–825My emergency protocol
If a vascular complication is suspected, treatment follows the established international standard according to DeLorenzi. The decisive factor is time.
- Immediate diagnosisClinical assessment, capillary refill test, documentation of the affected vascular area. Ultrasound for localization of the filler depot for precise therapy planning.
- High-dose hyaluronidase administrationAccording to the established DeLorenzi protocol: high-dose injections directly into the ischemic area. In my practice, hyaluronidase is always in stock — it is the only true "emergency-stop button" of HA filler medicine.
- Adjuvant measuresAspirin, warm compresses, local vasodilation. In advanced stages: combination with further established procedures.
- Close monitoringRepeated clinical checks, if necessary repeated hyaluronidase administrations every hour, until perfusion is fully restored (DeLorenzi endpoint: normal capillary refill).
- In case of visual disturbanceImmediate referral to the eye clinic (University Hospital Erlangen) and parallel conservative measures. Every minute counts here.
Anesthesiology as the foundation of emergency care
A filler complication is, in the clinical sense, an emergency — and emergencies are part of the daily professional routine of an anesthesiologist. This experience is the structural foundation of my practice's emergency care.
Emergency medicine as a core competence
Anesthesiologists work in a clinical environment in which acute complications are an everyday reality: circulatory decompensations, airway problems, allergic reactions, emergency intubations. The structured approach under time pressure, the parallel management of multiple problems and the calm clinical assessment in stressful situations are part of daily anesthesiological work.
In aesthetic medicine this specifically means: if a rare complication occurs, in a practice with an anesthesiological background it does not unfold as an exceptional situation, but as a standardized treatment process — with an established emergency protocol, complete equipment and readiness for invasive measures if required.
Complete emergency equipment at the treatment site
Beyond the hyaluronidase stock, my practice is equipped with the complete anesthesiological emergency equipment:
- Adrenaline and antihistamines for allergic reactions
- Oxygen and ventilation capability
- Material for airway management
- Volume therapy and circulatory support
- ECG monitoring
- High-frequency ultrasound for ultrasound-guided hyaluronidase application
When one emergency becomes two
Hyaluronidase is highly effective but not risk-free. Anaphylactic reactions to the enzyme are reported in the literature with a frequency of approximately 0.05 to 0.1 %. In the already tense situation of a vascular complication, an additional anaphylaxis can occur — two time-critical problems in parallel.
This constellation is a familiar scenario in anesthesiological daily practice: simultaneous stabilization of multiple vital parameters, parallel pharmacological interventions, structured escalation. In my practice, the management of this double complication is prepared through corresponding stock and routine.
Precise localization as standard
Ultrasound-guided hyaluronidase injection corresponds to the current international standard according to DeLorenzi and the CMAC consensus. High-frequency duplex ultrasound enables direct visualization of the filler depot and the precise perivascular hyaluronidase application into the ischemic perfusion area.
Recent systematic reviews (Frontiers in Medicine 2025) show that ultrasound-guided application both reduces the required hyaluronidase dose and improves the success rate compared to blind procedures. The method is increasingly recommended as the preferred standard in specialized publications.
Three paths, depending on starting situation
Which path is right for you depends on where you were treated and how acute your situation is. Please classify yourself realistically.
You were treated in my practice
After your treatment, you received an emergency card with a direct number. This number is reachable 24/7 for acute complications — directly without detours.
If you do not have the card to hand: practice number during consultation hours or — for life-threatening symptoms — immediately 112.
You were treated in another practice
If you received a filler treatment in another practice and suspect complications, first contact your treating physician — they know the product used, the injection site and are primarily responsible.
If you cannot reach them or rapid acute care is required, I can offer acute treatment within my possibilities. Three important notes on this:
Important in case of acute symptoms: Do not wait passively for my callback if your symptoms are increasing. Concurrently go to the nearest emergency department or call 112.
If you cannot reach me and symptoms are acute: dial the emergency number immediately 112 or go to a emergency department with appropriate expertise — University Hospital Erlangen or Klinikum Nuremberg are the suitable points of contact in the region.
Emergency with life-threat
In case of respiratory distress, impaired consciousness, sudden vision loss or signs of severe allergic reaction (swelling in the throat, generalized rash, circulatory failure): no telephone consultation — immediate emergency call.
Most complications are reversible. For vascular events recognized early and treated immediately, the recovery rate according to the DeLorenzi protocol is near 100 % — without lasting scars. Prerequisite: treatment as far as possible within the first hours, at the latest 48 hours.
My aim is, through ultrasound-guided injection to minimize the risk preventively from the outset. Should an event nevertheless occur, hyaluronidase is part of the standard equipment in my practice — and my patients have a direct way to reach me.
What patients typically ask
How likely are serious complications?
Very unlikely. Severe vascular complications are described in the specialist literature as very rare events. A MAUDE database analysis (Ortiz et al. 2022) documented 585 delayed complication cases against millions of annual treatments. In the overwhelming majority of cases, these are harmless, transient reactions such as small hematomas or swellings.
How quickly must one act in case of an acute complication?
As quickly as possible. For an acute occlusion at the treatment table: immediate stop of injection and immediate hyaluronidase administration — a prepared practice can achieve this within minutes. For late complications, the optimal treatment window is within the first hours, prognostically good up to 48 hours, limited up to 72 hours. If you are unsure: better to call once too early than too late.
What does emergency treatment cost in your practice?
For my own patients, the acute treatment of a complication following a treatment performed in my practice is part of medical duty of care and will not be billed additionally.
For external patients — that is, treatments performed in another practice — this is a private medical acute service in a private practice. Billing is according to GOÄ and is to be paid privately, even for those with public insurance. We discuss the expected costs transparently in the telephone call before a visit.
Do you also treat patients who were not in your practice?
In principle yes, within my possibilities and capacities. Three important points you should know: First — my practice is a private practice, acute treatment is billed privately according to GOÄ. Second — availability depends on my daily schedule; not every acute request can be served immediately. Third — if you cannot reach me, leave a message on the answering machine; I will call back as soon as possible, on the weekend if possible. If callback is not reachable or there is acute threat: 112 or directly an emergency department with expertise — University Hospital Erlangen or Klinikum Nuremberg.
Should I massage the face if I suspect complications?
No. Self-performed massage can displace filler material and in rare cases worsen secondary complications. Targeted lymphatic drainage to reduce swelling is performed — if at all — only by trained personnel under medical direction.
What sets your practice apart in the complication case?
Three factors: Hyaluronidase is always in stock, I use ultrasound-guided localization for precise filler diagnostics in the complication case, and my patients reach me directly via the emergency direct number on the personal card — without detours through secretariat or answering machine.
Source reference: The underlying recommendations follow the established international standard according to DeLorenzi (Aesthet Surg J 2017;37(7):814–825) as well as updated consensus recommendations (Murray et al., J Clin Aesthet Dermatol 2021;14(5):E61–E69). These publications are publicly accessible peer-reviewed specialist articles.
Note: This page serves general educational purposes and does not replace individual medical consultation or emergency treatment. In case of acute symptoms, contact the appropriate office according to your situation. In case of life-threat, immediately emergency call 112.
Legal notice: This text is an editorial educational article within the framework of the medical duty to inform (§ 8 MBO-Ä). It contains no product-related advertising in the sense of § 10 para. 1 HWG. Hyaluronidase is an active-substance name (INN), not a brand name.
Skin Analysis
Wrinkles & Muscle Relaxants
Bio-Regeneration (Skin Quality)
HIFU Lifting
Primary Care Support
Tension & Pain
Hair Health & Hair Loss
Skin Diseases
Drip Spa & Infusion Medicine
